Status:
UNKNOWN
Double Trigger in Patients With Low Proportion of Mature Oocytes
Lead Sponsor:
Riyadh Fertility and Reproductive Health center
Conditions:
Infertility, Female
Eligibility:
FEMALE
18-35 years
Phase:
PHASE2
Brief Summary
The aim of this randomized controlled trial is to determine whether co-administration of GnRH agonist and hCG for final oocyte maturation ( 40 and 34 h prior to oocyte retrieval , respectively) can in...
Eligibility Criteria
Inclusion
- Patients with history of low proportion of mature oocytes in previous IVF attempt (triggered by HCG).
- Patients with 6 to 15 mature follicles on the day oocyte trigger in the current IVF-ET attempt
Exclusion
- Endometriosis
- PCOS
Key Trial Info
Start Date :
May 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 2 2021
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04407052
Start Date
May 30 2020
End Date
February 2 2021
Last Update
May 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Riyadh Fertility and Reproductive Health center
Giza, Egypt